"The US Food and Drug Administration (FDA) has approved the tumor necrosis factor inhibitor adalimumab (Humira, AbbVie) for the treatment of moderate to severe hidradenitis suppurativa (HS), making it the first and only FDA-approved therapy"...
Mentax® (butenafine HCl cream), 1%, is indicated for the topical treatment of the following dermatologic infections: tinea (pityriasis) versicolor due to M. furfur (formerly P. orbiculare), interdigital tinea pedis (athlete's foot), tinea corporis (ringworm) and tinea cruris (jock itch) due to E. floccosum, T. mentagrophytes, T. rubrum, and T. tonsurans. Butenafine HCl cream was not studied in immunocompromised patients. (See DOSAGE AND ADMINISTRATION Section).
DOSAGE AND ADMINISTRATION
Patients with tinea (pityriasis) versicolor should apply Mentax® (butenafine) once daily for two weeks. In the treatment of interdigital tinea pedis, Mentax® (butenafine) should be applied twice daily for 7 days OR once daily for 4 weeks (NOTE: in separate clinical trials, the 7-day dosing regimen was less efficacious than the 4-week regimen (see Clinical Studies Section). While the clinical significance of this difference is unknown, these data should be carefully considered before selecting the dosage regiment for patients at risk for the development of bacterial cellulitis of the lower extremity associated with interdigital cracking/fissuring).
Patients with tinea corporis or tinea cruris should apply Mentax® (butenafine) once daily for two weeks.
Sufficient Mentax® (butenafine) Cream should be applied to cover affected areas and immediately surrounding skin of patients with tinea versicolor, interdigital tinea pedis, tinea corporis, and tinea cruris. If a patient shows no clinical improvement after the treatment period, the diagnosis and therapy should be reviewed.
Mentax® (butenafine HCl cream) Cream, 1%, is supplied in tubes in the following sizes:
15-gram tube (NDC 62794-151-02)
30-gram tube (NDC 62794-151-03)
STORE BETWEEN 5°C and 30°C (41° and 86°F).
Manufactured by: DPT Laboratories San Antonio, TX 78215. Distributed by: Bertek Pharmaceuticals Inc. Morgantown, WV 26505. June 6, 2001.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 4/3/2009
Additional Mentax Information
Mentax - User Reviews
Mentax User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.